Shorepoint Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.97M | Sell |
33,266
-1,614
| -5% | -$338K | 1.58% | 16 |
|
|
2024
Q4 | $6.2M | Sell |
34,880
-256
| -0.7% | -$45.5K | 1.42% | 22 |
|
|
2024
Q3 | $6.94M | Sell |
35,136
-1,941
| -5% | -$383K | 1.58% | 21 |
|
|
2024
Q2 | $6.36M | Sell |
37,077
-53
| -0.1% | -$9.09K | 1.49% | 21 |
|
|
2024
Q1 | $6.76M | Sell |
37,130
-2,319
| -6% | -$422K | 1.65% | 16 |
|
|
2023
Q4 | $6.11M | Sell |
39,449
-6,982
| -15% | -$1.08M | 1.64% | 16 |
|
|
2023
Q3 | $6.92M | Sell |
46,431
-3,341
| -7% | -$498K | 2.03% | 14 |
|
|
2023
Q2 | $6.71M | Sell |
49,772
-3,508
| -7% | -$473K | 1.89% | 16 |
|
|
2023
Q1 | $8.49M | Sell |
53,280
-7,310
| -12% | -$1.17M | 2.43% | 6 |
|
|
2022
Q4 | $9.79M | Buy |
60,590
+11,608
| +24% | +$1.88M | 2.72% | 4 |
|
|
2022
Q3 | $6.57M | Buy |
48,982
+725
| +2% | +$97.3K | 3.14% | 4 |
|
|
2022
Q2 | $7.39M | Sell |
48,257
-3,569
| -7% | -$547K | 3.12% | 3 |
|
|
2022
Q1 | $8.4M | Sell |
51,826
-3,969
| -7% | -$643K | 3.51% | 3 |
|
|
2021
Q4 | $7.56M | Buy |
55,795
+485
| +0.9% | +$65.7K | 3.07% | 6 |
|
|
2021
Q3 | $5.97M | Buy |
+55,310
| New | +$5.97M | 2.68% | 8 |
|
|
2021
Q1 | $5.28M | Sell |
48,743
-27,620
| -36% | -$2.99M | 2.82% | 5 |
|
|
2020
Q4 | $8.18M | Buy |
76,363
+138
| +0.2% | +$14.8K | 4.54% | 2 |
|
|
2020
Q3 | $6.68M | Sell |
76,225
-2,858
| -4% | -$250K | 4.15% | 3 |
|
|
2020
Q2 | $7.76M | Sell |
79,083
-11,064
| -12% | -$1.09M | 5.06% | 2 |
|
|
2020
Q1 | $6.87M | Sell |
90,147
-4,897
| -5% | -$373K | 5.51% | 2 |
|
|
2019
Q4 | $8.42M | Sell |
95,044
-1,155
| -1% | -$102K | 4.81% | 1 |
|
|
2019
Q3 | $7.28M | Buy |
96,199
+2,983
| +3% | +$226K | 4.3% | 3 |
|
|
2019
Q2 | $6.78M | Buy |
93,216
+6,123
| +7% | +$445K | 3.87% | 3 |
|
|
2019
Q1 | $7.02M | Buy |
+87,093
| New | +$7.02M | 3.97% | 3 |
|